期刊文献+

丙型肝炎病毒抗体胶体金免疫层析法的建立 被引量:4

Development of Hepatitis C Virus Antibody Colloidal Gold Immunization Assay
下载PDF
导出
摘要 目的建立一种快速定性检测人血清丙型肝炎病毒(HCV)抗体的方法。方法根据双抗原夹心法的实验原理,建立胶体金免疫层析法检测人血清中丙型肝炎病毒抗体。结果检测中国食品药品检定研究院快速法丙型肝炎病毒抗体国家参考品,20份阴性参考品、20份阳性参考品符合率均为100%;最低检出限参考品L1(1∶8,1∶16)和L2(1∶64,1∶128)均能检出阳性;平行测定10条重复性参考品,全部阳性且显色强度一致。检测1050份血清,与酶联免疫法的符合率达到96.9%。经RIBA复核确认,本方法灵敏度为97.9%,特异性为99.0%。结论本分析方法提供了一种更方便、快速的检测人血清中的HCV抗体的方法,具有很大的临床价值。 Objective To establish a rapid colloid gold method to determine hepatitis C virus antibody in patients' serum. Methods The anti-HCV antibodies in sera of human were detected by using a double-antigen sandwich gold immunochromatographic assay(GICA). Results Testing the national reference panel for anti-HCV and the true positive rate was 100% and the true negative rate was 100%. The sensitivity was 1:16 (L1) and 1 : 128 (L2). Parallel determination of 10 trips of precision reference and the results were all positive and the color level was the same. For the evaluation of 1050 serum samples, the sensitivity of the strip rapid test method was 96.9% agreeable with enzyme-linked immunoassay. Conclusion By the RIBA, the diagnostic specificity and accuracy of anti-HCV were 97.9 % and 99.0%. Conclusion:We developed a GICA system for detecting anti-HCV antibodies, which can be widely used in clinical testing.
作者 郑嘉庚 程缤雁 ZHENG Jia- geng;CHENG Bin- yan(Beijing North Institute of Biological Technology ,Beijing 100076, China)
出处 《标记免疫分析与临床》 CAS 2018年第5期732-735,749,共5页 Labeled Immunoassays and Clinical Medicine
关键词 丙型肝炎病毒抗体 胶体金免疫层析法 丙型肝炎 双抗原夹心法 Hepatitis C virus antibody Gold immunochromatographic assay HCV Doubleantigen sandwich
  • 相关文献

参考文献5

二级参考文献31

  • 1陈均,李琼芝.多厂家ELISA试剂检测抗-HCV结果不一致的确证[J].临床输血与检验,2001,3(3):26-27. 被引量:1
  • 2唐正运,徐建英,李贵华.血清第三代抗-HCV与第二代抗-HCV及HCV-RNA检测结果的比较分析[J].广东医学,1997,18(1):4-6. 被引量:1
  • 3卢建恩 陶其敏 马大龙 等.丙型肝炎病毒E1基因序列抗原高度表达及表达产物的初步应用[J].中华实验和临床病毒杂志,2001,15(1):20-20.
  • 4季阳.输血传播的疾病.[A].见:杨成民 李家增 季阳..基础输血学[C].北京.中国科学技术出版社,2001.400.
  • 5戴志澄,祁国明.中国病毒性肝炎血清流行病学调查(上卷),1992-1995.北京:科学技术文献出版社,1995:60-71.
  • 6Liang XF, Bi SL, Yang WZ, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine, 2009,27 : 6550-6557.
  • 7卫生部.全国人群乙型病毒性肝炎血清流行病学调查报告.北京:人民卫生出版社,2011:1-70.
  • 8Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol, 2003,38 Suppl: S 1042-1048.
  • 9Halasz R, Weiland O, Sallberg M. GB virus C/hepatitis G virus. Scand J Infect Dis, 2001,33 (8) : 572-580.
  • 10Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C infection. Lancet Infect Dis, 2005,5 : 558-567.

共引文献347

同被引文献22

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部